Market Data
MarketsGilead to Buy Cancer Biotech Tubulis in $5B Deal
Gilead to Buy Cancer Biotech Tubulis in $5B Deal
Related Articles
Architect Norman Foster on Hong Kong's Ever-Changing Skyline
neutral
Bloomberg
10 minutes ago
Horizons Middle East & Africa 4/9/2026
neutral
Bloomberg
38 minutes ago
FTSE 100 Live: Stocks called higher as oil edges up over Hormuz closure
neutral
Yahoo Finance
about 1 hour ago
Thai Central Bank Pledges Long Rate Pause to Support Economy
neutral
Bloomberg
about 2 hours ago
You May Also Like
Architect Norman Foster on Hong Kong's Ever-Changing Skyline
Bloombergβ’10 minutes ago
Horizons Middle East & Africa 4/9/2026
Bloombergβ’38 minutes ago
FTSE 100 Live: Stocks called higher as oil edges up over Hormuz closure
Yahoo Financeβ’about 1 hour ago
Thai Central Bank Pledges Long Rate Pause to Support Economy
Bloombergβ’about 2 hours ago
FTSE 100 to Extend Gains as Relief Rally Halts Elsewhere
Bloombergβ’about 2 hours ago
Iran-US Truce in Doubt as Israel Strikes Lebanon
Bloombergβ’about 2 hours ago